These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 19074171

  • 1. Effects of rituximab on resistant SLE disease including lung involvement.
    Reynolds JA, Toescu V, Yee CS, Prabu A, Situnayake D, Gordon C.
    Lupus; 2009 Jan; 18(1):67-73. PubMed ID: 19074171
    [Abstract] [Full Text] [Related]

  • 2. B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus.
    Podolskaya A, Stadermann M, Pilkington C, Marks SD, Tullus K.
    Arch Dis Child; 2008 May; 93(5):401-6. PubMed ID: 18039744
    [Abstract] [Full Text] [Related]

  • 3. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
    Smith KG, Jones RB, Burns SM, Jayne DR.
    Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
    [Abstract] [Full Text] [Related]

  • 4. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.
    Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA.
    Arthritis Rheum; 2009 Apr 15; 61(4):482-7. PubMed ID: 19333973
    [Abstract] [Full Text] [Related]

  • 5. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA.
    Rheumatology (Oxford); 2005 Dec 15; 44(12):1542-5. PubMed ID: 16188950
    [Abstract] [Full Text] [Related]

  • 6. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W.
    Ann Rheum Dis; 2008 Jul 15; 67(7):1011-6. PubMed ID: 17962238
    [Abstract] [Full Text] [Related]

  • 7. Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience.
    Lateef A, Lahiri M, Teng GG, Vasoo S.
    Lupus; 2010 May 15; 19(6):765-70. PubMed ID: 20118162
    [Abstract] [Full Text] [Related]

  • 8. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M.
    J Rheumatol; 2008 May 15; 35(5):826-33. PubMed ID: 18398943
    [Abstract] [Full Text] [Related]

  • 9. Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response.
    Jónsdóttir T, Gunnarsson I, Risselada A, Henriksson EW, Klareskog L, van Vollenhoven RF.
    Ann Rheum Dis; 2008 Mar 15; 67(3):330-4. PubMed ID: 17827182
    [Abstract] [Full Text] [Related]

  • 10. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
    Garcia-Carrasco M, Mendoza-Pinto C, Sandoval-Cruz M, Soto-Vega E, Beltran-Castillo A, Jimenez-Hernandez M, Graillet D, Gonzalez L, Rojas-Rodriguez J, Pineda-Almazana A, Zamudio-Huerta L, Lopez-Colombo A.
    Lupus; 2010 Feb 15; 19(2):213-9. PubMed ID: 19965944
    [Abstract] [Full Text] [Related]

  • 11. Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen.
    Ezeonyeji AN, Isenberg DA.
    Rheumatology (Oxford); 2012 Mar 15; 51(3):476-81. PubMed ID: 22096015
    [Abstract] [Full Text] [Related]

  • 12. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus.
    Marks SD, Patey S, Brogan PA, Hasson N, Pilkington C, Woo P, Tullus K.
    Arthritis Rheum; 2005 Oct 15; 52(10):3168-74. PubMed ID: 16200620
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
    Tokunaga M, Fujii K, Saito K, Nakayamada S, Tsujimura S, Nawata M, Tanaka Y.
    Rheumatology (Oxford); 2005 Feb 15; 44(2):176-82. PubMed ID: 15494350
    [Abstract] [Full Text] [Related]

  • 14. An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA.
    Arthritis Rheum; 2002 Oct 15; 46(10):2673-7. PubMed ID: 12384926
    [Abstract] [Full Text] [Related]

  • 15. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M, Chaudhry A, Jones RB, Sivasothy P, Jani P, Jayne D.
    Clin Otolaryngol; 2009 Aug 15; 34(4):328-35. PubMed ID: 19673980
    [Abstract] [Full Text] [Related]

  • 16. Rituximab therapy for childhood-onset systemic lupus erythematosus.
    Willems M, Haddad E, Niaudet P, Koné-Paut I, Bensman A, Cochat P, Deschênes G, Fakhouri F, Leblanc T, Llanas B, Loirat C, Pillet P, Ranchin B, Salomon R, Ulinski T, Bader-Meunier B, French Pediatric-Onset SLE Study Group.
    J Pediatr; 2006 May 15; 148(5):623-627. PubMed ID: 16737873
    [Abstract] [Full Text] [Related]

  • 17. Repeated B cell depletion in treatment of refractory systemic lupus erythematosus.
    Ng KP, Leandro MJ, Edwards JC, Ehrenstein MR, Cambridge G, Isenberg DA.
    Ann Rheum Dis; 2006 Jul 15; 65(7):942-5. PubMed ID: 16269424
    [Abstract] [Full Text] [Related]

  • 18. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X, Club Rheumatismes et Inflammation (CRI).
    Ann Rheum Dis; 2005 Jun 15; 64(6):913-20. PubMed ID: 15550531
    [Abstract] [Full Text] [Related]

  • 19. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.
    Pediatrics; 2009 Jan 15; 123(1):e159-63. PubMed ID: 19074962
    [Abstract] [Full Text] [Related]

  • 20. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S, Menegatti E, La Grotta R, Modena V.
    Nephrol Dial Transplant; 2011 Dec 15; 26(12):3987-92. PubMed ID: 21385860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.